Determination of ceftazidime in plasma and cerebrospinal fluid by micellar electrokinetic chromatography with direct sample injection

A simple micellar electrokinetic chromatography (MEKC) with UV detection at 254 nm for analysis of ceftazidime in plasma and in cerebrospinal fluid (CSF) by direct injection without any sample pretreatment is described. The separation of ceftazidime from biological matrix was performed at 25 degrees C using a background electrolyte consisting of Tris buffer with sodium dodecyl sulfate (SDS) as the electrolyte solution. Under optimal MEKC condition, good separation with high efficiency and short analyses time is achieved. Several parameters affecting the separation of the drug from biological matrix were studied, including pH and concentration of the Tris buffer and SDS. Using cefazolin as an internal standard (IS), the linear ranges of the method for the determination of ceftazidime in plasma and in CSF were all over the range of 3-90 microg/mL; the detection limit of the drug in plasma and in CSF (signal-to-noise ratio = 3; injection 0.5 psi, 5 s) was 2.0 microg/mL. The applicability of the proposed method for determination of ceftazidime in plasma and CSF collected after intravenous administration of 2 g ceftazidime in patients with meningitis was demonstrated.     

Development of a new high-performance liquid chromatographic method for the determination of ceftazidime

A rapid, accurate, and sensitive high-performance liquid chromatographic (HPLC) method was developed and validated for the determination of ceftazidime in pharmaceuticals. The method validation parameters yielded good results and included range, linearity, precision, accuracy, specificity, and recovery. The excipients in the commercial powder for injection did not interfere with the assay. Reversed-phase chromatography was used for the HPLC separation on a Waters C18 (WAT 054275; Milford, MA) column with methanol-water (70 + 30, v/v) as the mobile phase pumped isocratically at a flow rate of 1.0 mL/min. The effluent was monitored at 245 nm. The calibration graph for ceftazidime was linear from 50.0 to 300.0 microg/mL. The values for interday and intraday precision (relative standard deviation) were <1%. The results obtained by the HPLC method were calculated statistically by analysis of variance. We concluded that the HPLC method is satisfactory for the determination of ceftazidime in the raw material and pharmaceuticals.     

High-Pressure Liquid Chromatographic Analysis for Quantitation of BMY-28142 and Ceftazidime in Human and Rabbit Serum

Abstract

The quantitative measurement of BMY-28142 and ceftazidime in serum after protein precipitation were compared using a reverse-phase liquid chromatographic (LC) method. Detection using ultraviolet absorbance at 275 nm gave a sensitivity of 1.0 mcg/ml and 1.5 mcg/ml for BMY-28142 and ceftazidime respectively, and both gave linear response to concentration of at least 80 mcg/ml. Drug recovery after sample deproteination was 104% for BMY-28142 in rabbit serum and 93% in human serum. Results indicate a precise and accurate assay for this drug can be obtained using a simple LC method.     

高效液相色谱法测定头孢他啶的含量及杂质

采用高效液相色谱法测定了头孢他啶的含量及杂质。以Alltima C18色谱柱(250 mm×4.6 mm,5 μm)为分离柱,以乙腈和磷酸盐缓冲溶液(pH 3.9)分别为流动相A和流动相B进行梯度洗脱,流速1.3 mL/min,柱温35 ℃,紫外检测波长255 nm。从头孢他啶药物中共分出14个杂质,且14个杂质间具有良好的分离度。头孢他啶在0.267~1069 μg/mL范围内与峰面积具有良好的线性关系(r=1.0000);其定量限(S/N=10)和最低检出限(S/N=3)分别为3.1 ng和0.93 ng。3个浓度的日内测定值的相对标准偏差(RSD）为0.72%(n=3),日间测定值的RSD为0.91%(n=3)。头孢他啶溶液在4 ℃避光条件下放置24 h保持稳定。本方法与欧洲/英国药典和日本药局方的方法比较,具有分离杂质数量多、分离度好的优点。     

Simultaneous Quantification of Ceftazidime and Pyridine,its Main Degradation Product,by High-Performance Liquid Chromatography

ABSTRACT

A high performance liquid chromatographic method for the simultaneous assay of ceftazidime and pyridine, the principal degradation product of ceftazidime, is described. The method was fully validated in terms of recovery, linearity, selectivity and precision. An application was done on stability of ceftazidime at 40 mg.mL¹ in infusion solutions 0.9% NaCl and 5% glucose on 24 hours in ambulatory infusion device. Quantification results of pyridine were more linear and accurate than ceftazidime. Pyridine was a good label in ceftazidime stability studies.     

硝普钠分光光度法测定头孢他啶

建立了硝普钠分光光度法测定头孢他啶的方法。实验结果表明,在碱性条件下,头孢他啶与硝普钠以1∶2的化学计量比反应形成一种红褐色产物,其最大吸收波长为528 nm。 头孢他啶在2.50~810 mg/L浓度范围内与吸光度呈良好线性关系,线性回归方程为A=0.02704+0.00218ρ(mg/L),线性相关系数r＝0.9987,表观摩尔吸收系数ε528=1.2×103 L/(mol·cm),检测限(3σ/k)为1.38 mg/L。 本方法操作简便、快速,成功用于药品中头孢他啶含量的测定。     

流动注射化学发光法测定头孢他啶

在碱性条件下,头孢他啶对金纳米粒子催化高锰酸钾氧化鲁米诺化学发光体系的发光强度具有明显的增敏作用,基于此建立了一种测定头孢他啶的化学发光方法.在优化实验条件下,用该法测定头孢他啶的线性范围为3.0×10-5～5.0×10-2 g/L,检出限为1.0×10-5 g/L,相对标准偏差为2.0%(ρ=4.0×10-3 g/L...     

Metalloantibiotics: synthesis and antibacterial activity of ceftazidime metal complexes

Ceftazidime (Hceftaz) interacts with transition metal(II) ions to give octahedral [M(ceftaz)(H₂O)Cl] complexes [M = Mn(II), Fe(II), Co(II), Ni(II), Cu(II) and Cd(II)] which were characterized by physicochemical and spectroscopic methods. The spectra indicated that the ligand is a multidentate chelating agent. The complexes are insoluble in water and common organic solvents and probably have polymeric structures. The antibacterial activity of the metal complexes was found to be lower than that of free ceftazidime.     

New metal(II) complexes with ceftazidime Schiff base

Complexes of Co(II), Ni(II) and Cu(II) with the Schiff base (LH) derived from ceftazidime and salicylaldehyde were synthesized. The proposed structures of the new metal complexes based on the results of elemental analyses, molar conductivity, IR, DRUV and ¹H NMR spectra, effective magnetic moment and thermal analysis were discussed. The surface morphology of Schiff base and metal complexes was studied by SEM. The composition of the metal complexes was ML₂, where L is the deprotonated Schiff base ligand and M = Co(II), Ni(II) and Cu(II). IR spectral data indicated the Schiff base ligand being bidentately coordinated to the metallic ions with N and O atoms from azomethine and phenolic groups. All the complexes have square-planar geometry and are nonelectrolytes. The thermal analysis recorded that TG, DTG, DTA and DSC experiments confirmed the assigned composition and gave information about the thermal stability of complexes in dynamic air atmosphere. Theoretical investigation of the molecular structure of Schiff base ligand and its complexes was studied using programs dedicated to chemical modeling and quantomolecular calculation of chemical properties. The newly synthesized complexes were tested for in vitro antibacterial activity against selected Gram-negative and Gram-positive bacterial strains, and they exhibited an antibacterial activity superior to that of the Schiff base ligand.     

Synthesis of functionalized Cu:ZnS nanosystems and its antibacterial potential

Copper doped Zinc Sulfide (Cu:ZnS) nanoparticles were synthesized as potential antibacterial agents, through a solvothermal approach using Mercaptosuccinic acid (MSA) and Sodium citrate (SC) as differential capping agents. Multiple variants of the Cu:ZnS nanoparticles were generated based on the refluxing intervals of the reactions and a choice of the capping agents. The microstructural properties and the elemental composition of the synthesized nanosystems were examined using Scanning Electron Microscopy (SEM) and powder X-ray Diffraction (XRD), along with Energy-Dispersive X-ray spectroscopy (EDX) and Microwave Plasma-Atomic Emission Spectroscopy (MP-AES). The as-synthesized nanosystems were also characterized for their surface attributes using Fourier Transform Infrared spectroscopy (FT-IR), while the optical properties were studied using UV–Vis spectroscopy. The electrostatic stability of the aqueous dispersions of Cu:ZnS was studied as a function of their solvent pH, using Photon Correlation Spectroscopy. For the assessment of the antibacterial properties of the different variants of Cu:ZnS nanosystems, the disk diffusion assay was performed against both Gram-positive and Gram-negative bacteria. The results show a promising antibacterial activity for the Cu:ZnS variants synthesized, with a prominent activity in the [email protected]:ZnS nanoparticle making them a novel class of potential antibacterial agents.     

苯磺酰苯丙氨酸、邻菲咯啉Mg(Ⅱ)配合物的合成、晶体结构及抗菌活性

以MgCl2、苯磺酰苯丙氨酸(BPPA)和邻菲咯啉为原料,合成了一个新型镁配合物[Mg(BPPA)2(phen)(H2O)2].(phen).2(H2O)。对其进行了元素分析、红外光谱分析,并用X-射线衍射测定了它的单晶结构。结果表明:配合物属于三斜晶系,P空间群,配合物分子通过分子内和分子间氢键以及π-π堆积作用形成了一维链状结构。初步研究了配体及配合物的抗菌活性,配合物对大肠杆菌、白葡萄球菌及枯草芽孢杆菌有一定的抗菌活性,而配体却没有抗菌活性。     

Antibacterial and antioxidant properties of phyto-synthesized silver nanoparticles using Lavandula stoechas extract

Due to environmentally friendly and cost- effective issues, biological methods for silver nanoparticles (AgNPs) synthesis are advantageous over chemical and physical ones. In this study, AgNPs synthesized using Lavandula stoechas extract as a reductant and its antioxidant capacity, antibacterial property and cytotoxicity effect were investigated. The phyto-synthesized AgNPs were characterized using various analyses such as transmission electron microscopy (TEM), scanning electron microscopy (SEM), x-ray diffraction (XRD) as well as Fourier transform infrared (FT-IR). The prepared nanoparticles were spherical on shape with the size about 20–50 nm. Antibacterial studies through agar disk diffusion method confirmed the antibacterial potential of phyto-synthesized AgNPs toward two clinical Staphylococus aureus and Pseudomonas aeruginosa bacteria, although MTT assay demonstrated that S. aureus (MIC = 125 μg/ml) was more susceptible to AgNPs than P. aeruginosa (MIC = 250 μg/ml). Moreover, the cytotoxicity assay of phyto-synthezied AgNPs showed a low cytotoxic effect on RAW264 cell line at 62.5 μg/ml as an effective concentration. Also the considerable antioxidant capacity of the AgNPs confirmed through DPPH assay. Great antibacterial and antioxidant properties along with biocompatibility make the suggested phyto-synthesized AgNPs a great candidate for different biomedical applications including wound healing.     

Determination of minor impurities in temafloxacin hydrochloride by high-performance liquid chromatography

Minor impurities in the antibacterial agent temafloxacin hydrochloride were determined using high-performance liquid chromatography. Manufacturing impurities and degradation products were separated using a reversed-phase system with gradient elution. Detector response was linear for the individual impurities to approximately 50 micrograms/ml which represents 2.5% of the drug concentration. The procedure provides quantitation of impurities to approximately the 0.05% level with precision (relative standard deviations) of 4.7% to 29% in typical bulk drug lots. A variety of reversed-phase columns were evaluated for the assay method with optimum resolution achieved using a 5-microns Nucleosil C18 packing.     

Synthetic cephalosporins. VI. Synthesis and antibacterial activity of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl) ethoxyiminoacetamido]- 3-(3-hydroxy-4-pyridon-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds

Synthesis and antibacterial activity of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyimin oacetamido]- 3-(3-hydroxy-4-pyridon-1-yl)-3-cephem-4-carboxylic acid (12) and its related compounds are described. Compound 12 exhibited excellent antibacterial activity against gram-negative bacteria, and its anti-pseudomonal activity was ten to fifteen times greater than that of ceftazidime.     

取代喹啉类化合物抗菌活性的定量构效关系及分子设计

采用密度泛函理论(DFT)和逐步回归分析法对15种新合成的取代喹啉类化合物进行了定量构效关系(QSAR)研究. 在B3LYP/6-31G(d,p)水平上计算了取代喹啉的量子化学参数, 通过逐步多元回归分析筛选出影响抗菌活性的主要因素, 建立了定量构效关系方程, 并用留一法交叉分析了模型的稳定性及预测能力. 结果表明, C5的亲核电子密度fNC5及C9-N1的键级BC9-N1是影响喹啉类化合物抗金黄色葡萄球菌活性的主要因素, 所得模型对该类化合物抗菌活性有较好的预测效果. 同时基于QSAR研究结果设计了4个活性较高的新喹啉衍生物.     

Determination of ceftazidime in dolphin serum by liquid chromatography with ultraviolet-visible detection and confirmation by thermospray liquid chromatography-mass spectrometry.

A simple and sensitive liquid chromatographic method has been developed for the determination of therapeutic levels of ceftazidime in dolphin serum. The method involved an ultrafiltration of diluted serum with an equal amount of acetonitrile-ethanol-water (40:40:20, v/v/v) through a 10,000 daltons molecular mass cut-off filter. Separation of ceftazidime from the other serum components was performed by ion-paired (dodecanesulfonate) liquid chromatography using a reversed-phase column eluted with acetonitrile-water solution. The ultraviolet absorbance of the column effluent was monitored in the 200-340 nm range of a photodiode-array detector or at 258.8 nm on a variable-wavelength ultraviolet-visible detector. Recoveries of ceftazidime from dolphin serum spiked with 20 and 2 micrograms/ml were 92.9 and 91.1% with coefficients of variation of 5.5 and 5.7%, respectively. A correlation coefficient of 0.9994 occurred with ceftazidime in aqueous solutions (n = 6, in duplicates). The limit of detection for this antibiotic was estimated to be approximately 50 ppb (ng/ml). The unbound ceftazidime concentrations in dosed dolphin serum were determined to calculate the protein bindings of this antibiotic which yielded 32 +/- 2%. The ceftazidime peak identity in dosed dolphin serum was confirmed by thermospray liquid chromatography-mass spectrometry. The thermospray mass spectrum of ceftazidime exhibited only the fragment ions, involving the opening of the beta-lactam ring, at m/z 237, 255 and 315 when positive-ion detection mode was employed and the fragment ions at m/z 235, 253 and 313 when negative-ion detection mode was used.     

Quantum-chemical parameters of 2-substituted 5-nitrofuran derivatives

Quantum-chemical parameters of molecules of 2-substituted 5-nitrofuran derivatives were calculated using the GAMESS software package and their correlation with the antibacterial activity of the compounds was analyzed. Regression analysis technique was employed to find linear relationships between the logarithm of the average inhibiting concentration of 5-nitrofuran derivatives and the quantum-chemical parameters. The largest correlation coefficient (0.932) was found for the dependence of the antibacterial activity on the amount of charge on the nitrogen atom of the nitro group. The results obtained are in agreement with modern concepts about the nature of the antibacterial activity of 2-substituted 5-nitrofuran derivatives.